NGM Biopharmaceuticals saw the highest growth of 0.32% in patent filings and no patents were granted in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.32% and no change in grants. GlobalData’s DataBook provides a comprehensive analysis of NGM Biopharmaceuticals’s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
NGM Biopharmaceuticals has been focused on protecting inventions in European Patent Office(EPO) with one publication in Q2 2024
The United States(US), World Intellectual Property Organization(WIPO), European Patent Office(EPO), and Israel(IL) patent Office are among the top ten patent offices where NGM Biopharmaceuticals is filings its patents. Among the top granted patent authorities, NGM Biopharmaceuticals has 100% of its grants in Israel(IL).
Roche and Eli Lilly and Co could be the strongest competitors for NGM Biopharmaceuticals
Patents related to rare diseases lead NGM Biopharmaceuticals's portfolio
NGM Biopharmaceuticals has the highest number of patents in rare diseases.in Q2 2024.
Liver cancer related patents lead NGM Biopharmaceuticals portfolio followed by diabetes, and choroidal neovascularization
NGM Biopharmaceuticals has highest number of patents in liver cancer followed by diabetes, choroidal neovascularization, preleukemia, and pre-diabetes/impaired glucose tolerance.
For comprehensive analysis of NGM Biopharmaceuticals's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
